RE: New yearly high5 Jan 2024 11:40
LLL - It is an about turn, but more to do with acknowledging my rotten luck and living within my means......namely dividend shares. Bagging a healthy yield is no bad thing. Currently, if I bank the divi, I'll make my money back on the original investment in 10 years. The dividend also rises 1p per year.
I'm with MrAmericano on this partly, in that the volatility is quite stark and worse still, it skews to the downside namely it wants to trade at a discount to NAV.
My personal opinion is BG should have a responsibility to temper any cowboy like manoeuvres to wrong foot the market and claim to know where the future lies. The result is where we have been for the last 12months. When the fund size is nearly $13bn, BG should demonstrate fiscal discipline with investor money to ensure a safety net. Slater and his sidekick state " investing in the agents of change trumps reacting to short-term headwinds." But they invest early in non-profitable companies burning through cash. They don't question cash burn and where are they going to get their funding from to support their quest. The portfolio realignment you see at present is far too late. Top 5 are cash generating. We knew early last year the FED was going to raise rates (too late BTW). BG would have cleaned up had they shifted to boring stocks such as MSFT, APPL, GOOG. Even in the pharma space, they should have had a stake in LLY, even if they started small. Buying more of MRNA early 2023 was nuts. COVID revs are what drove the stock, but when we emerged from the pandemic and people had their government funded 2 shots, where was the sustained revenues? People don't want to pay $100 for a vaccine unless death is guaranteed. People wing it just like we do with the annual flu vaccine. MRNA is a 2025 and beyond story. Yet Slater and Lawrence think they know otherwise. We kinda saw this at the November 2023 fireside chat. They looked uncomfortable.
Looking at the holdings, I wonder if there's going to be another push to purge Chinese holdings.
(Just seen MRNA is only 4.4% of their portfolio. Did they sell or buy more of other's?)
Timing is everything....you're right. Funny thing is I broke my mantra and jumped in too quickly without doing DD on Slater and Lawrence. I should have booked a small loss in Feb 23 rather than riding out the year. I would have bagged a 9% dividend in the meantime. I'm waiting for 810p before I exit. Unless they boot Slater and his buddy out and refresh with guys who remember the legacy of this IT and the image is has to maintain.
CaptainPicard - £12 is half way between £8 and £16. No science.